NCT03139370 2023-08-25Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced CancersGilead SciencesPhase 1 Terminated16 enrolled
NCT03733587 2020-05-14GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid TumorsGenexine, Inc.Phase 1 Completed24 enrolled